Burning Rock Biotech (BNR) Share Price, News & Analysis

Company Overview

Blenheim Natural Resources Plc invests in companies or assets in the natural resources and agribusiness sectors. It engages in establishing strategic and portfolio investments in listed and unlisted shares, as well as in projects in the natural resource sector covering the mining, oil and gas, and agricultural sectors. The company was formerly known as Coburg Group plc and changed its name to Blenheim Natural Resources Plc in September 2015. Blenheim Natural Resources Plc was incorporated in 1994 and is based in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 3.56 to 3.56
• 52-Week Range: N/A
• Volume: 200 shs
• Average Volume: 75 shs
• Market Capitalization: £3.77 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BNR Stock Analysis - Frequently Asked Questions

How do I buy shares of Burning Rock Biotech?

Shares of BNR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Burning Rock Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Burning Rock Biotech investors own include Clearside Biomedical (CLSD), Joint (JYNT), AbbVie (ABBV), Acasti Pharma (ACST), ADMA Biologics (ADMA), Adamis Pharmaceuticals (ADMP) and Akebia Therapeutics (AKBA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Diagnostic Imaging Centers
• Sub-Industry: Healthcare
• Current Symbol: LON:BNR
• CUSIP: N/A
• CIK: N/A
• Web: www.blenheimnaturalresources.com
• Phone: +44-1622-844601
• Fax: N/A
• Employees: 1,390
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 105,725,000
• Free Float: N/A
• Market Cap: £3.77 million
• Optionable: Not Optionable
• Beta: N/A